Health TechnologyMyPOPNCT05989308
MyChart Proxy Outreach to Parents (MyPOP)
A study testing Email, Text and Patient Portal Message in people with Health Technology, run by Yale University at 4 sites in United States.
Trial summary
The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Health Technology
- What is being tested?
- Email, Text and Patient Portal Message
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 5,200 participants
- Where
- 4 sitesUnited States
- Study dates
- 15 Oct 2024to Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Guardian of a child aged ≤12 years seen in one of the two identified health centers within the last 3 years with guardian status and contact information documented in the child's EHR
Who cannot join
- Preferred method of contact for guardians with no MyChart is telephone or physical letter to home
- Guardians with EHR proxy access already activated for all children in their care.
Trial locations and contacts
4 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United States4 sites, 4 recruiting
- Recruiting
Cornell Scott Hill Health Center
New Haven, Connecticut, 06511
- Recruiting
Fair Haven Community Health Center
New Haven, Connecticut, 06513
- Not yet recruiting
Yale New Haven Health
New Haven, Connecticut, 06520
- Not yet recruiting
Yale School of Medicine
New Haven, Connecticut, 06520
About this study
Official title: MyChart Proxy Outreach to Parents (MyPOP): Mode of Outreach to Parents for Proxy Patient Portal Enrollment
The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are:
- will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access).
- which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.
Read the detailed description
This study aims to evaluate the feasibility and impact of contacting parents/guardians of children seen in pediatric primary care practices to establish their proxy access to the EHR patient portal, called "MyChart." The primary objective of the study is to determine if directly messaging a guardian results in activation of proxy access to a child's MyChart at a higher rate compared with no specific messaging (usual care).
A secondary objective of the study is to compare messaging strategies, with one arm being a message to the guardian's patient portal, and the other text messaging.
Another secondary objective of the study is to ascertain whether sending information about activation to a guardian via text or email (as preferred) will result in self-activating their own Electronic Health Record (EHR) patient portal access.
At the conclusion of the study, the investigators will determine best-method for activation and utilize this method to invite guardians initially randomized to the usual-care arm of the study.
- Conditions
- Health Technology
- Being tested
- Email, Text, Patient Portal Message
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EmailBehavioural
Email message sent to guardian with proxy information.
TextBehavioural
Text message sent to guardian with proxy information.
Patient Portal MessageBehavioural
Patient portal message (MyChart) to guardian with proxy information.
| Study group | Role | What they receive |
|---|---|---|
| Usual Care | No intervention | Care as usual |
| Preferred Modality | Experimental | Text or email message to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart. Receives: Behavioral: Email; Behavioral: Text |
| Patient Portal | Experimental | Patient portal message (MyChart) to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart. Receives: Behavioral: Patient Portal Message |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of participants who activate MyChart Proxy Access
Proportion of participants who activate access to the patient portal of the child's EHR, also known as MyChart Proxy Access, of all those invited. Proxy MyChart activation is a binary function (yes, has proxy activated; no, does not have proxy activated).
Measured: up to 12 weeks
Secondary outcomes (1)
Proportion of guardians' who activate a personal MyChart account
Proportion of guardians' who activate a personal MyChart account, for those without accounts at the outset. Investigators will report if guardians activate their patient portal as a result of activation messaging. This is a binary function (yes, has active patient portal; no, does not have active patient portal).
Measured: up to 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2023
- Study start15 Oct 2024
- Primary completionSep 2026 (estimated)
- Study completionSep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Health TechnologyStudies of the same condition, open and under way.
- More trials run by Yale UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- JDAT will access EHR visit data for these offices to establish the child patient pool and identify guardians.
- Masking
- None (open label)
- Enrolment
- 5,200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Yale University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ada Fenick, MD, Principal investigator, Yale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05989308
- Sponsor's protocol ID
- 2000034372
- Other IDs
- 000
- Acronym
- MyPOP
- Status last verified
- Feb 2026
- First submitted
- 2 Aug 2023
- Last updated
- 13 Feb 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Deidentified data per the PIs discretion.
Study at a glance
From the registry record, last updated by the sponsor on 13 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- MyChart Proxy Outreach to Parents (MyPOP): Mode of Outreach to Parents for Proxy Patient Portal Enrollment
- ClinicalTrials.gov ID
- NCT05989308
- Acronym / sponsor ID
- MyPOP / 2000034372
- Conditions
- Health Technology
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 5,200 participants (estimated)
- Lead sponsor
- Yale UniversityUniversity, hospital or other
- Study start
- 15 Oct 2024 (actual)
- Primary completion
- Sep 2026 (estimated)
- Study completion
- Sep 2026 (estimated)
- First posted
- 14 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are:
- will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access).
- which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.
Detailed description
This study aims to evaluate the feasibility and impact of contacting parents/guardians of children seen in pediatric primary care practices to establish their proxy access to the EHR patient portal, called "MyChart." The primary objective of the study is to determine if directly messaging a guardian results in activation of proxy access to a child's MyChart at a higher rate compared with no specific messaging (usual care).
A secondary objective of the study is to compare messaging strategies, with one arm being a message to the guardian's patient portal, and the other text messaging.
Another secondary objective of the study is to ascertain whether sending information about activation to a guardian via text or email (as preferred) will result in self-activating their own Electronic Health Record (EHR) patient portal access.
At the conclusion of the study, the investigators will determine best-method for activation and utilize this method to invite guardians initially randomized to the usual-care arm of the study.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- JDAT will access EHR visit data for these offices to establish the child patient pool and identify guardians.
| Arm | Type | Receives |
|---|---|---|
| Usual Care | No intervention | –Care as usual |
| Preferred Modality | Experimental | Behavioral: Email, Behavioral: TextText or email message to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart. |
| Patient Portal | Experimental | Behavioral: Patient Portal MessagePatient portal message (MyChart) to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Guardian of a child aged ≤12 years seen in one of the two identified health centers within the last 3 years with guardian status and contact information documented in the child's EHR
Key exclusion criteria (2 listed)
- Preferred method of contact for guardians with no MyChart is telephone or physical letter to home
- Guardians with EHR proxy access already activated for all children in their care.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EmailEmail message sent to guardian with proxy information. | Behavioural | Preferred Modality |
| TextText message sent to guardian with proxy information. | Behavioural | Preferred Modality |
| Patient Portal MessagePatient portal message (MyChart) to guardian with proxy information. | Behavioural | Patient Portal |
Primary outcome
Proportion of participants who activate MyChart Proxy Access
Time frame: up to 12 weeks
Proportion of participants who activate access to the patient portal of the child's EHR, also known as MyChart Proxy Access, of all those invited. Proxy MyChart activation is a binary function (yes, has proxy activated; no, does not have proxy activated).
1 secondary outcome
Proportion of guardians' who activate a personal MyChart account
Time frame: up to 12 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Feb 2026.
- Individual participant dataSharing planned: Yes. Deidentified data per the PIs discretion.
Related trials for Health Technology
Not yet recruiting
REM Enhancement Sleep Technology for Well-being, Emotion, and Life Lift
Healthy Adult Participants
Not yet recruiting
Smoking Cessation Program for Lao People With HIV
Smoking Cessation, HIV
Recruiting
Dietary Intervention Study on Liver Health in Young Adults
Liver Health
Recruiting
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
Obesity
Not yet recruiting
Advancing Cardiovascular Health Among Adolescents With Intellectual Disabilities: Co-Development of Technology Interventions to Enhance Physical Activity
Physical Activity, Intellectual Disabilities
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ada Fenick, MD principal investigator
Yale University
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Email, Text and Patient Portal Message in people with Health Technology, run by Yale University at 4 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ada Fenick, MD (203-688-2475, Ada.fenick@yale.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of participants who activate MyChart Proxy Access (time frame: up to 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.